Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma
Clinical trial NCT02513342 · UNKNOWN
Trial details
- NCT number
- NCT02513342
- Sponsor
- Nanjing NingQi Medicine Science and Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2017-10-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.